Cefazolin injection reduces the rate of postoperative endophthalmitis

Article

Administering cezafolin injections after cataract surgery reduces the rate of postoperative endophthalmitis.

Administering cefazolin injections after cataract surgery reduces the rate of postoperative endophthalmitis, claims a study in the journal Bio Med Central.

Dr Pedro Romero-Aroca et al., Ophthalmology Service. Hospital Universitari Sant Joan, IISPV, Universidad Rovira i Virgili, Reus, Spain, conducted a prospective, observational study on 25001 patients.

All participants were divided into two groups: Group 1, consisting of 11696 patients, was operated on between January 2002 and December 2002 and Group 2, with 13305 patients, was administered a 1 mg/0.1 bolus of intracameral cefazolin between January 2003 and December 2009.

Of the patients studied, there were 76 cases of endophthalmitis in Group 1, compared to 7 in Group 2. Postoperative endophthalmitis rate decreased from 0.63% to 0.05% after a cefazolin. The relative risk of endophthalmitis in Group 1, compared to Group 2, was 11.45.

Intracameral bolus injections of cefazolin after cataract surgery significantly reduce the rate of postoperative endophthalmitis.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.